|
|
| MRD / Regn No. |
: 20260000575 |
Date |
: 25/06/2026 |
| Patient Name |
: Anup Hazarika |
Age & Gender |
: 46 Yrs. / Male |
| Contact No. |
: 9101100659 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
|
Subjective |
: |
DM FOR 6 YEARS,TAKING MEDICATIONS IRREGULAR |
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,DR CHANGES IN THE FUNDUS,MILD TSH ELEVATION,VITAMIN D DEFICEINCY,INCREASED TGL,A3G2 DKD,NEPHROTIC RANGE PROTEINURIA |
|
Plan |
: |
OPTHALMOLOGY OPINION FOR FUNDUS CHANGES,ADD SGLT2I GLP1RA,NEPHROLOGY OPINON,ADD VITAMIN D,SEE ME IN 1 MONTH |
|
| Salient Investigations |
: |
ECG ELECTROCARDIOGRAM DESCRIPTIVE: PROLONGED QTC | QTC INTERVAL: 512 sec | CREATININE: 1.01 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 84.76 mL/min/1.73m2 |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION SEMAGLUTIDE
SEMATRINITY 0.25
Medicine For DIABETES HEART AND KIDNEY PROTECTION |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
|
| MAY CAUSE NAUSEA VOMITING OR VISUAL DISTURBANCES | |
|
2 |
TABLET IMEGLIMIN SR 1000 MG
IMEGLYN SR
Medicine For GLUCOSE CONTROL |
PO |
1-0-1 |
BEFORE FOOD
|
TILL NEXT VISIT |
|
|
3 |
SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
4 |
TELMISARTAN 40 MG
TELMA 40 MG |
|
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
5 |
GEL CHOLECALCIFEROL 60000 IU
ARACHITOL NANO
Medicine For VITAMIN D |
PO |
ONCE A WEEK |
DRINK LIQUID AS IS
|
6 WEEKS |
|
|
6 |
CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
7 |
TABLET FENOFIBRATE 200 MG
LIPICARD 200 MG |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 25/Jun/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP URINE MICROALBUMIN |
| |
|
| |
|
|
